105 related articles for article (PubMed ID: 1530302)
1. [Pharmacokinetic studies of continuous and bolus intraportal 5-fluorouracil infusion].
Hanai A; Yamamura T; Matsuzaki H; Oikawa H; Kikuchi K; Ozasa T; Akaishi O; Senda T; Katayama K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1536-9. PubMed ID: 1530302
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
[TBL] [Abstract][Full Text] [Related]
3. [Dose, administration time and route and hepatic function-dependent metabolism of 5-FU in mice].
Okamoto M; Takao A; Fujita H
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3483-90. PubMed ID: 3789759
[TBL] [Abstract][Full Text] [Related]
4. [Superior mesenteric arterial infusion chemotherapy in patient with both peritoneal carcinomatosis and liver metastasis].
Ueshima Y; Taniguchi H; Miyata K; Suganuma Y; Takeuchi K; Oguro A; Tsukuda N; Takahashi T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1731-3. PubMed ID: 1530343
[TBL] [Abstract][Full Text] [Related]
5. [An experimental study on portal infusion of 5-fluorouracil].
Ishida H; Iwama T; Nishioka Y; Endo S; Okubo Y; Imajo M; Otomo M; Mishima Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1884-8. PubMed ID: 1877831
[TBL] [Abstract][Full Text] [Related]
6. Tissue levels of chemotherapeutic agents for hepatic metastasis during hepatic arterial and portal injection.
Kaneko A; Naomoto Y; Aoyama M; Tanaka N
In Vivo; 1999; 13(2):195-8. PubMed ID: 10363178
[TBL] [Abstract][Full Text] [Related]
7. Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis.
Tsujitani S; Watanabe A; Kakeji Y; Maehara Y; Tomoda H; Furusawa M; Sugimachi K
Eur J Surg Oncol; 1991 Oct; 17(5):526-9. PubMed ID: 1936301
[TBL] [Abstract][Full Text] [Related]
8. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
9. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group].
Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an experimental model for continuous intraportal infusion of chemo/immunotherapeutic agents in the rat.
Rafique M; Adachi W; Shiohara E
Anticancer Res; 1995; 15(5B):1869-72. PubMed ID: 8572571
[TBL] [Abstract][Full Text] [Related]
11. [An experimental study on portal infusion of 5-fluorouracil (the second report)].
Ishida H; Iwama T; Ide A; Nihei Z; Imajo M; Mishima Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1532-5. PubMed ID: 1530301
[TBL] [Abstract][Full Text] [Related]
12. [Early adjuvant intraportal chemotherapy with 5-fluorouracil after hepatic resection of colorectal metastasis: a preliminary clinical and pharmacokinetic study].
Seitz JF; Aubert C; Giovannini M; Delpero JR; Houvenaeghel G; Guerinel G; Carcassonne Y
Bull Cancer; 1989; 76(10):1127-32. PubMed ID: 2635640
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study of 5-FU + leucovorin therapy by continuous arterial infusion].
Mori T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2838-41. PubMed ID: 2789495
[TBL] [Abstract][Full Text] [Related]
14. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
[TBL] [Abstract][Full Text] [Related]
15. [Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer].
Adachi W; Watanabe H; Yazawa K; Koide N; Koike S; Mihara M; Nakata S; Kajikawa S; Kuroda T; Amano J
Gan To Kagaku Ryoho; 1998 Apr; 25(5):697-703. PubMed ID: 9571967
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion].
Mori T; Iwasaki Y; Takahashi K; Takahashi T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1547-9. PubMed ID: 1530305
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer].
Fujii K; Nakashima K; Ohno T; Anai H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies on drug uptake by metastatic liver tumor after intra-arterial, intraportal and intravenous administration of BrdU].
Shioaki Y; Taniguchi H; Itoh A; Daidoh T; Seiki K; Yamaguchi T; Sawai K; Takahashi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2829-32. PubMed ID: 2782892
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic comparison of intraperitoneal and intravenous 5-Fu administration].
Qing SH
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):340-2. PubMed ID: 1782844
[TBL] [Abstract][Full Text] [Related]
20. [Arterial infusion chemotherapy of 5-FU and leucovorin for patients with liver metastases from colorectal cancer].
Yamamura T; Hanai A; Oikawa H; Matsuzaki H; Kikuchi K; Akaishi O; Seo K; Ozasa T; Katayama K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1516-9. PubMed ID: 8373209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
